8th Annual Duke Multidisciplinary Benign Urology Research Symposium!

April 20, 2023
Trent Semans Center, Duke University

Topic: Urologic Congenitalism and Development – Impact from Prenatal to Adult Life

Panel discussions ★ poster sessions ★ trainee oral presentations
trainee monetary awards ★ trainee lunch with experts

Faculty, fellows, postdocs, students, and staff from all disciplines with an interest in any aspect of benign urological diseases are invited to attend.

Registration and abstract submission open January 30, 2023

QUESTIONS? Please contact us at [email protected]

Call for Applications Open!

The Duke Multidisciplinary K12 Urologic Career Development Program (KURe) is a K12 institutional career development grant funded by the NIH/NIDDK. We seek qualified clinical, translational, and basic science researchers (MDs, DOs, PhDs, and MD/PhDs) from diverse disciplines who are interested in building an independent research career using collaborative, multidisciplinary approaches to benign urological research questions.

Application deadline: Oct. 7, 2022
Anticipated start date: Nov. 1, 2022

All the information is here:

CSR- Early Career Reviewer Program

The Center for Scientific Review (CSR) at the National Institutes of Health invites early career scientists to join our Early Career Reviewer program. Participants gain first-hand NIH grant review experience which can be helpful in preparing their own grants.

In brief, the program is open to those who:

  • Have at least 1 year of independent research experience (assistant professors and similar roles; associate professors are not eligible and post-docs are not eligible)
  • Have not held an R01 or equivalent
  • Have at least one senior-authored publication (first, last, or corresponding) since earning a Ph.D. or M.D. and at least one in the last 2 years
  • Have submitted an NIH grant application and received the summary statement

Details and the application can be found here:

Questions are welcome – [email protected]


ICS 2022

52nd Annual Meeting of the International Continence Society
7-10 September 2022
Vienna, Austria

The ICS Meetings give centre-stage to cutting-edge continence research, putting a spotlight on the latest clinical practices, and providing a variety of career opportunities for those interested in continence related issues.
The Meeting is multidisciplinary and welcomes urologists, gynaecologists, physiotherapists, nurses, midwives, research scientists, and all those dedicated to improving the lives of patients suffering from continence conditions.
The abstract and workshop submissions are now open and will close on 4th April.

If you’re worried about submitting because of COVID-19, we will make sure that if your abstract is accepted, you will have some capacity to present your work whether you can attend or not.

7th Annual Multidisciplinary Benign Urology Research Symposium
April 28 and 29, 2022, virtual 1-5pm
Keynotes  Panel discussions  Platform presentations
Trainee Awards  Small Group Discussion with Experts

Keynote speakers include J. Curtis Nickel, MD, and Karl-Dietrich Sievert, MD, PhD, and discussions will be on chronic urologic pain disorders and the science of the underactive bladder.

Faculty, fellows, postdocs, students, and staff from all disciplines with an interest in any aspect of benign urological diseases are invited to attend.

Registration and abstract submission are open. Abstract submission closes March 29, 2022.

SBUR Annual Meeting is now fully virtual!

Visit our meetings page for the full agenda and registration information! 

Posted 9/23/2021

Congratulations to the Newly Elected SBUR Executive Committee!

William A. Ricke, PhD
Vice President 2021-2022

James D. Brooks, MD
Member At-Large 2021-2023

Christina A.M. Jamieson, PhD
Secretary 2021-2023

2020 SBUR Annual Meeting is going virtual!

Following consultation with past leadership of our society, the SBUR Executive Committee and the Program Planning Committee have come to a consensus to run the 2020 Annual Meeting as a virtual event.  While we would have welcomed the opportunity to be together in person, the current restrictions on travel and the ongoing pandemic continue to present challenges.

The Program Planning Committee have put together a superb program and we are looking forward to a successful event! Stay tuned for more information! 

Congratulations to the Newly Elected SBUR Executive Committee!

Haojie Huang, Ph.D  
Vice President 2020-2021

Amina Zoubeidi, Ph.D
Director At-Large 2020-2022

Douglas W. Strand, Ph.D
Director At-Large 2020-2022

SBUR is hosting it’s first virtual meeting! We have a fantastic line up of speakers! Meeting agendas can be found here. Don’t delay and register today!

NIDDK Funding Announcement

The National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) is pleased to announce the release of a new funding announcement titled “Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required).”  This Funding Opportunity Announcement encourages the submission of pilot and feasibility clinical trials conducted in humans that will lay the foundation for larger clinical trials related to the prevention and/or treatment of diseases and conditions within the mission of NIDDK. The program will support small, short-term clinical trials in humans to acquire preliminary data regarding the effects of the intervention, as well as feasibility data related to recruitment and retention and study conduct.

Applications for clinical trials submitted under this FOA should have clearly described aims and objectives and have a high likelihood that the trial findings will lead to a more definitive, hypothesis-driven trial to improve understanding, diagnosis, prevention or treatment of the diseases studied and have the potential to impact clinical practice and/or public health.

Please note:  Preliminary data regarding intervention efficacy are not required. The announcement is available at

The NIDDK encourages individuals and organizations to promote and disseminate this RFA information in related newsletters, publications, or on organizational websites.  To request additional information, please email a point of contact for each division:

  • For inquiries related to Kidney, Urologic and Hematologic Diseases, please email Dr. Susan Mendley at: [email protected].
  • For inquiries related to Diabetes, Endocrinology and Metabolic Diseases, please email Dr. Barbara Linder at [email protected].
  • For inquiries related to Digestive Diseases and Nutrition, please email Dr. Aynur Unalp-Arida at: [email protected].

Earliest submission date is May 5th, 2020. 

Posted: 4/9/2020

Click here to register. More information below!

Congratulations 2019 Urology Care Foundation Awardees of Distinction!

These awards will be presented at the Urology Care Foundation Research Honors Program and Reception on May 4, 2019 at the AUA Annual Meeting in Chicago, IL.

View Award Recipients

Message from SBUR President Allen C. Gao, MD, PhD

These awards will be presented at the Urology Care Foundation Research Honors Program and Reception on May 4, 2019 at the AUA Annual Meeting in Chicago, IL.

Susan Kasper, PhD
Vice President (2019–2020)
Dr.Kasper Bio

Benyi Li, MD, PhD
Treasurer-Elect (2019–2020, then Treasurer 2020–2022)
Dr. Li Bio

Leigh Ellis, PhD
At-Large Director (2019–2021)
Dr. Ellis Bio

Congratulations to our newly elected Executive Committee members and thank you to all our exceptional candidates for their steadfast dedication to SBUR.

I look forward to seeing you at the SBUR Spring Meeting during AUA2019 at the Chicago McCormick Place, and I hope you will join us at our Members Luncheon at 12pm on May 4th as well.

Message from SBUR President Dr. Allen C. Gao

Dear Colleagues,

It is with a heavy heart that we announce the passing of Dr. Denise O’Keefe.  Denise died peacefully in her home on Sunday morning, March 17, 2019.

Denise was a talented and dedicated scientist, professor, mentor, wife, and mother.  Denise received her Bachelor of Science degree with honors in genetics from La Trobe University, Australia. She then completed her Ph.D. training in 1995 at the University of Adelaide, where she studied ABO blood group genetics and hematologic malignancies. For her postdoctoral training, Denise moved to the United States to work in the laboratory of Ben Tycko at the Columbia University College of Physicians and Surgeons in New York, where she continued to study cancer genetics.  Denise then moved to train with Skip Heston at the Memorial Sloan-Kettering Cancer Center, and later at the Cleveland Clinic, where she and her husband, Dean Bacich, made important contributions to the understanding of the genetics and biology of PSMA (prostate specific membrane antigen).  Her seminal work in the Heston laboratory defined the structural organization of the PSMA gene, its promoter, and PSMA homologs.  Denise and Dean were recruited for their first faculty appointments at the University of Pittsburgh, where they continued to study the role of PSMA and folate metabolism in prostate cancer biology and epigenetics. In 2007, Denise received the SBUR Young Investigator award for her work on PSMA and prostate cancer. In 2014, Denise and Dean moved to the University of Texas Health at San Antonio, in the Department of Urology and the Mays Cancer Center, where they have continued to their important work on prostate cancer genetics, PSMA biology, and folate metabolism.  Denise and her laboratory have received several SBUR awards over the years for their pioneering work and dedication to urologic research.  This year, Denise was promoted to Professor of Urology and awarded the Quincy and Estine Lee Endowment in Cancer Research.

Our thoughts are with Denise’s family at this time as we collectively mourn the loss of an incredible friend and colleague.